Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome
J Med Virol
.
2023 Jan;95(1):e28128.
doi: 10.1002/jmv.28128.
Epub 2022 Sep 22.
Authors
Mohnad Abdalla
1
,
Amr Ahmed El-Arabey
2
,
Zhongtao Gai
1
Affiliations
1
Research Institute of Pediatrics, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.
2
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
PMID:
36068170
PMCID:
PMC9539041
DOI:
10.1002/jmv.28128
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Hypertension* / complications
Post-Acute COVID-19 Syndrome